Developmental Consequences of Defective ATG7-Mediated Autophagy in Humans: Defective ATG7-Mediated Autophagy in Humans

Jack J. Collier, Claire Guissart, Monika Olahova, Souphatta Sasorith, Florence Piron-Prunier, Fumi Suomi, David Zhang, Nuria Martinez-Lopez, Nicolas Leboucq, Angela Bahr, Silvia Azzarello-Burri, Selina Reich, Ludger Schoels, Tuomo M. Polvikoski, Pierre Meyer, Lise Larrieu, Andrew M Schaefer, Hessa S. Alsaif, Suad Alyamani, Stephan ZuchnerInes A. Barbosa, Charu Deshpande, Angela Pyle, Anita Rauch, Matthis Synofzik, Fowzan S. Alkuraya, Francois Rivier, Mina Ryten, Robert McFarland, Agnes Delahodde, Thomas G. McWilliams, Michel Koenig, Robert W. Taylor

Forskningsoutput: TidskriftsbidragArtikelVetenskapligPeer review

Sammanfattning

Background Autophagy is the major intracellular degradation route in mammalian cells. Systemic ablation of core autophagy-related (ATG) genes in mice leads to embryonic or perinatal lethality, and conditional models show neurodegeneration. Impaired autophagy has been associated with a range of complex human diseases, yet congenital autophagy disorders are rare.

Methods We performed a genetic, clinical, and neuroimaging analysis involving five families. Mechanistic investigations were conducted with the use of patient-derived fibroblasts, skeletal muscle-biopsy specimens, mouse embryonic fibroblasts, and yeast.

Results We found deleterious, recessive variants in human ATG7, a core autophagy-related gene encoding a protein that is indispensable to classical degradative autophagy. Twelve patients from five families with distinct ATG7 variants had complex neurodevelopmental disorders with brain, muscle, and endocrine involvement. Patients had abnormalities of the cerebellum and corpus callosum and various degrees of facial dysmorphism. These patients have survived with impaired autophagic flux arising from a diminishment or absence of ATG7 protein. Although autophagic sequestration was markedly reduced, evidence of basal autophagy was readily identified in fibroblasts and skeletal muscle with loss of ATG7. Complementation of different model systems by deleterious ATG7 variants resulted in poor or absent autophagic function as compared with the reintroduction of wild-type ATG7.

Conclusions We identified several patients with a neurodevelopmental disorder who have survived with a severe loss or complete absence of ATG7, an essential effector enzyme for autophagy without a known functional paralogue. (Funded by the Wellcome Centre for Mitochondrial Research and others.)

Genetic Deficit in the Cellular Sanitation System Autophagy is a cellular process through which toxic aggregates, pathogens, and damaged organelles are disposed of and essential metabolites recycled. This study challenges the belief that a core autophagy protein is indispensable.

Originalspråkengelska
TidskriftNew England Journal of Medicine
Volym384
Nummer25
Sidor (från-till)2406-2417
Antal sidor12
ISSN0028-4793
DOI
StatusPublicerad - 24 juni 2021
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3124 Neurologi och psykiatri
  • 3112 Neurovetenskaper
  • 3111 Biomedicinska vetenskaper
  • 1184 Genetik, utvecklingsbiologi, fysiologi
  • 1182 Biokemi, cell- och molekylärbiologi

Citera det här